1. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained
- Author
-
Caroline M.A. Swanink, Martijn Rutten, Amelieke J. H. Cremers, Bert Mulder, Heiman F. L. Wertheim, Kirsten K.T. Dirkx, and Annelies Post
- Subjects
Adult ,Microbiology (medical) ,medicine.medical_specialty ,Pneumococcal disease ,Coronavirus disease 2019 (COVID-19) ,Referral ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Infectious and parasitic diseases ,RC109-216 ,medicine.disease_cause ,Pneumococcal Infections ,Article ,Pneumococcal Vaccines ,All institutes and research themes of the Radboud University Medical Center ,Streptococcus pneumoniae ,Pandemic ,medicine ,Humans ,Intensive care medicine ,Pandemics ,Netherlands ,Surveillance ,SARS-CoV-2 ,business.industry ,Transmission (medicine) ,Incidence ,Incidence (epidemiology) ,Infant ,Diagnostic test ,COVID-19 ,General Medicine ,medicine.disease ,IPD ,Pneumococcal infections ,Infectious Diseases ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,S. pneumoniae ,business - Abstract
Streptococcus pneumoniae is the main bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less pneumococcal disease was identified by surveillance systems around the world. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates. Here, we explore additional factors that have contributed to the instant drop in pneumococcal disease cases captured in surveillance. Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance. Depending on setting, we discuss alternative monitoring strategies that could improve sight on pneumococcal disease dynamics.
- Published
- 2021